two
holstein
four
jersey
calv
day
old
bodi
weight
kg
enrol
studi
calv
ad
libitum
access
starter
hay
water
throughout
studi
three
calv
use
twice
studi
allow
rest
interv
week
calv
deem
healthi
base
physic
examin
hematolog
analysi
calv
clinic
normal
start
experi
determin
vital
sign
physic
appear
milk
intak
urin
fece
product
dryness
cool
mucou
membran
sink
eye
eyelid
skin
tent
approxim
sec
main
clinic
sign
observ
follow
induct
diarrhea
calv
becam
dehydr
metabol
acidosi
induc
secondari
diarrhea
caus
follow
acidif
procedur
calv
prime
cold
milk
prepar
ad
g
commerci
milk
replac
powder
motoku
milk
calf
scientif
feed
laboratori
co
ltd
tokyo
japan
l
cold
water
milk
administ
twice
day
day
feed
tube
start
end
acidif
procedur
base
excess
hemoglobin
concentr
hb
bhba
measur
cathet
surefrow
cathet
terumo
tokyo
japan
insert
right
jugular
vein
consciou
calv
cathet
connect
ordinari
drip
tube
control
flow
rate
calv
randomli
assign
iss
group
iv
infus
iss
ar
group
iv
infus
ar
ard
group
iv
infus
ard
calv
receiv
mlkg
design
solut
flow
rate
mlkghr
result
flow
rate
dextros
gkghr
initi
fluid
infus
design
time
base
venou
blood
sampl
collect
base
well
hr
initi
fluid
therapi
venou
blood
sampl
anaerob
collect
heparin
syring
left
jugular
vein
tip
syring
cap
collect
sixteen
diarrheic
calv
nine
holstein
male
four
holstein
femal
three
crossbr
holstein
japanes
black
male
mean
age
day
rang
day
old
bodi
weight
approxim
kg
enrol
clinic
studi
calv
ad
libitum
access
starter
hay
water
throughout
studi
dehydr
metabol
acidosi
secondari
diarrhea
diagnos
calv
veterinari
practition
basi
physic
examin
blood
ga
analysi
istat
abbott
lab
north
chicago
il
usa
calv
c
parvum
detect
use
c
parvum
rapid
test
kit
cosmo
bio
co
ltd
tokyo
japan
cathet
surefrow
cathet
terumo
insert
right
jugular
vein
connect
ordinari
drip
tube
control
flow
rate
calv
randomli
assign
ar
iv
infus
ar
ard
group
iv
infus
ard
calv
receiv
mlkg
ar
ard
flow
rate
mlkghr
result
flow
rate
dextros
gkghr
venou
blood
sampl
collect
base
well
hr
initi
fluid
therapi
venou
blood
sampl
anaerob
collect
heparin
syring
left
jugular
vein
tip
syring
cap
collect
betahydroxybutyr
concentr
analyz
whole
blood
sampl
use
automat
analyz
precis
xceed
abbott
lab
hematocrit
hct
hb
measur
use
automat
ga
analyz
istat
abbott
lab
chang
rel
plasma
volum
rpv
calcul
hb
hct
use
accept
formula
data
express
mean
standard
deviat
experiment
model
clinic
studi
mean
valu
depend
variabl
compar
base
valu
within
group
use
oneway
anova
follow
dunnett
test
measur
depend
variabl
experiment
model
compar
group
sampl
collect
period
use
oneway
anova
follow
tukey
hsd
test
measur
depend
variabl
clinic
studi
compar
group
sampl
collect
period
use
student
ttest
mannwhitney
utest
follow
ftest
signific
level
set
p
figur
show
sequenti
chang
venou
bhba
measur
follow
acidif
procedur
measur
decreas
significantli
mm
p
bhba
level
increas
mm
although
differ
signific
bhba
concentr
calv
increas
mm
therefor
acidif
procedur
use
studi
deem
suitabl
induc
metabol
acidosi
ketosi
clinic
sign
moist
cough
jugular
vein
congest
ptosi
saliv
arrhythmia
observ
experiment
period
group
moist
lung
sound
appreci
auscult
associ
sever
clinic
sign
present
calv
iss
group
calv
ar
group
urin
observ
first
time
min
min
min
initi
fluid
therapi
iss
ar
ard
group
respect
rpv
iss
ar
ard
group
increas
steadili
throughout
studi
period
reach
respect
end
fluid
infus
hr
rpv
found
significantli
increas
base
valu
p
dunnett
test
sequenti
chang
rpv
iss
ar
ard
group
significantli
differ
group
venou
ph
iss
ar
ard
group
chang
significantli
base
valu
end
fluid
therapi
respect
concentr
iss
ar
ard
group
remain
constant
throughout
infus
period
measur
iss
group
slightli
decreas
compar
base
valu
end
fluid
therapi
chang
signific
although
measur
ar
ard
group
slightli
increas
time
point
compar
base
valu
chang
signific
signific
chang
measur
group
observ
studi
figur
show
sequenti
chang
venou
bhba
concentr
experiment
model
bhba
concentr
iss
ar
group
increas
slightli
reach
mm
respect
end
infus
hr
valu
significantli
increas
compar
base
valu
contrast
ard
infus
induc
progress
signific
decreas
bhba
concentr
reach
mm
hr
initi
fluid
therapi
remain
level
throughout
procedur
p
dunnett
test
base
valu
plasma
glucos
iss
ar
ard
group
mgdl
respect
signific
increas
plasma
glucos
concentr
induc
calv
receiv
ard
valu
reach
mgdl
min
initi
fluid
therapi
remain
mgdl
throughout
remaind
procedur
plasma
glucos
concentr
ard
group
decreas
slightli
reach
gdl
hr
initi
fluid
therapi
calv
receiv
mlkg
ar
ard
administ
min
min
respect
calv
observ
diarrhea
accompani
dehydr
metabol
acidosi
clinic
sign
impair
central
nervou
system
function
includ
ataxia
coma
observ
fluid
infus
clinic
sign
moist
cough
jugular
vein
congest
ptosi
saliv
arrhythmia
observ
experiment
period
either
group
moist
rale
note
auscult
trembl
neither
sever
observ
calv
ar
group
calv
ard
group
calv
die
studi
period
clinic
sign
impair
central
nervou
system
function
consist
fece
chang
significantli
either
group
fluid
infus
calv
clinic
dehydr
eye
sunken
mm
orbit
space
observ
eyelid
eyebal
end
fluid
infus
group
monitor
urin
base
hr
initi
fluid
therapi
urin
observ
calv
ar
group
calv
ard
group
calv
ar
group
urin
observ
calv
ard
group
urin
observ
twice
studi
figur
show
rpv
bhba
calv
receiv
fluid
infus
rpv
ar
ard
group
increas
steadili
procedur
reach
respect
end
fluid
infus
p
dunnett
test
sequenti
chang
rpv
significantli
differ
group
venou
ph
ar
ard
group
chang
significantli
baselin
end
fluid
infus
valu
increas
respect
concentr
ar
ard
group
remain
constant
throughout
infus
period
measur
calv
ar
group
calv
ard
group
slightli
increas
compar
base
valu
end
fluid
infus
decreas
mm
respect
howev
chang
signific
bhba
concentr
ar
group
slightli
increas
compar
base
valu
end
fluid
infus
increas
mm
mm
end
infus
howev
chang
signific
contrast
ard
infus
induc
progress
signific
decreas
bhba
concentr
reach
mm
end
fluid
infus
p
dunnett
test
sequenti
chang
bhba
concentr
ard
group
significantli
greater
ar
group
p
base
valu
plasma
glucos
ar
ard
group
mgdl
respect
signific
increas
plasma
glucos
concentr
induc
calv
ard
infus
reach
mgdl
min
initi
fluid
therapi
remain
mgdl
throughout
procedur
howev
plasma
glucos
concentr
return
mgdl
hr
initi
fluid
therapi
ar
ard
group
plasma
potassium
concentr
decreas
slightli
throughout
procedur
reach
meql
respect
end
fluid
infus
p
plasma
sodium
chlorid
concentr
chang
end
fluid
infus
ar
ard
group
studi
iv
infus
ar
ard
found
effect
increas
plasma
volum
correct
howev
iv
infus
ard
prevent
catabol
suggest
necessari
use
ar
ard
properli
administr
ar
appropri
earli
stage
diarrhea
typifi
dehydr
metabol
acidosi
progress
exhaust
meanwhil
ard
infus
may
benefici
wast
diarrheic
calv
dehydr
metabol
acidosi
mani
consist
clinic
patholog
chang
observ
calv
diarrhea
cholera
toxin
vibrio
cholera
heat
labil
toxin
lt
e
coli
caus
secretori
diarrhea
clinic
studi
c
parvum
isol
diarrheic
calv
follow
infect
clinic
sign
peak
day
last
day
c
parvum
damag
small
intestin
villi
result
failur
electrolyt
water
absorpt
malabsorpt
diarrhea
calv
diarrhea
result
dehydr
increas
dlactat
concentr
neg
energi
balanc
caus
anorexia
malabsorpt
nutrient
hypoglycemia
report
diarrheic
calv
found
weak
letharg
comatos
hypoglycemia
often
occur
combin
hyperlactatemia
typic
observ
termin
stage
diseas
therefor
intraven
fluid
therapi
must
suppli
suffici
sodium
normal
extracellular
fluid
ecf
volum
provid
alkal
agent
correct
metabol
acidosi
provid
energi
calv
diarrhea
state
neg
energi
balanc
studi
use
experiment
model
clinic
studi
evalu
whether
dextros
administ
intraven
diarrheic
calv
effect
treatment
acidif
procedur
use
studi
significantli
decreas
mm
p
gener
calf
mm
diagnos
sever
metabol
acidosi
therefor
acidif
procedur
use
studi
suitabl
method
induc
mild
acidosi
experiment
model
infus
iss
ar
ard
found
safe
effect
increas
plasma
volum
signific
differ
three
group
rel
chang
plasma
volum
end
fluid
therapi
clinic
studi
iv
infus
ar
ard
found
effect
increas
plasma
volum
signific
differ
ar
ard
group
rel
chang
plasma
volum
end
fluid
therapi
result
indic
ar
ard
infus
appropri
treatment
dehydr
calv
howev
end
fluid
therapi
rpv
ar
group
found
increas
significantli
ard
group
possibl
osmot
diuresi
caus
hyperglycemia
ard
group
possibl
explan
differ
rpv
distribut
fluid
plasma
interstiti
compart
ard
group
appear
differ
ar
ard
infus
use
purpos
rehydr
intraven
infus
ar
result
rapid
rehydr
iv
infus
ard
experiment
model
rel
chang
iss
group
slightli
decreas
end
fluid
therapi
iss
group
chlorid
concentr
increas
significantli
mmoll
base
mmoll
end
therapi
p
barker
report
iv
infus
salin
solut
result
sever
acidosi
caus
increas
serum
chlorid
level
therefor
caus
decreas
iss
group
could
increas
serum
chlorid
level
suggest
iss
may
limit
use
calv
metabol
acidosi
experiment
model
measur
calv
ar
group
calv
ard
group
increas
fluid
therapi
similarli
clinic
studi
measur
calv
ar
group
calv
ard
group
increas
fluid
therapi
chang
signific
either
experiment
model
clinic
studi
appear
differ
ar
ard
infus
correct
intraven
infus
iss
experiment
model
iv
infus
ar
experiment
model
clinic
studi
induc
catabol
intraven
infus
iss
ar
led
increas
bhba
concentr
rehydr
nakatpas
pump
cori
cycl
could
activ
calv
diarrhea
use
energi
form
atp
consequ
iss
ar
without
dextros
prevent
exhaust
contrari
experiment
model
clinic
studi
demonstr
iv
infus
ard
prevent
catabol
suggest
addit
dextros
maintain
glycometabol
inhibit
increas
bhba
caus
lipolysi
experiment
model
ard
infus
induc
rapid
signific
decreas
bhba
clinic
studi
ard
infus
result
signific
decreas
bhba
valu
end
fluid
therapi
suggest
exhaust
occur
sever
clinic
studi
experiment
model
sever
investig
report
addit
dextros
fluid
maintain
blood
glucos
inhibit
glyconeogenesi
result
breakdown
skelet
muscl
format
keton
bodi
patient
undergo
surgeri
control
therefor
ard
contain
dextros
may
use
treatment
wast
diseas
like
diarrhea
infect
c
parvum
shown
induc
sever
villou
atrophi
calv
lead
malabsorpt
diarrhea
absorpt
impair
due
loss
matur
villou
epitheli
cell
associ
transport
well
decreas
total
surfac
area
prevent
catabol
mainten
adequ
nutrit
addit
dextros
iv
fluid
solut
may
effect
oral
administr
dextros
addit
dextros
iv
fluid
solut
may
lead
hyperglycemia
increas
blood
insulin
may
caus
rebound
phenomenon
infus
dextrosecontain
fluid
experiment
model
use
studi
hypoglycemia
observ
ard
group
garei
et
al
report
addit
either
g
dextros
l
iv
fluid
contain
salin
sodium
bicarbon
given
hr
result
decreas
milk
intak
calv
neonat
diarrhea
similarli
iv
infus
ard
may
affect
intak
milk
starter
mcmanu
et
al
report
hyperglycemia
led
immunosuppress
surgeri
human
thu
sever
investig
indic
hyperglycemia
desir
outcom
follow
fluid
therapi
futur
studi
need
determin
appropri
method
incorpor
dextros
iv
fluid
solut
